- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03190473
OPTIMIZE IDE for the Treatment of ACS (OPTIMIZE)
March 21, 2023 updated by: Svelte Medical Systems, Inc.
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions.
The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm
Study Overview
Study Type
Interventional
Enrollment (Actual)
1630
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kamakura, Japan
- Shonan Kamakura General Hospital
-
Kanazawa, Japan
- Kanazawa Cardiovascular Hospital
-
Kitakyushu, Japan
- Kokura Memorial Hospital
-
Kobe, Japan
- Medical Corporation Association Sakura Association Takahashi Hospital
-
Kurashiki, Japan
- Ohara HealthCare Foundation Kurashiki Central Hospital
-
Kurume, Japan
- Shin Koga Hospital
-
Miyazaki, Japan
- Miyazaki Medical Association
-
Okayama, Japan
- The Sakakibara Heart Institute of Okayama
-
Sapporo, Japan
- Sapporo Higashi Tokushukai Hospital
-
-
-
-
-
Amersfoort, Netherlands
- Meander Medisch Centrum
-
Amsterdam, Netherlands
- OLVG loc Oost
-
Blaricum, Netherlands
- Tergooi Ziekenhuis
-
Breda, Netherlands
- Amphia Ziekenhuis
-
Den Haag, Netherlands
- Haga ziekenhuis
-
Dordrecht, Netherlands
- Albert Schweitzer Ziekenhuis
-
Eindhoven, Netherlands
- Catharina Ziekenhuis
-
Nieuwegein, Netherlands
- St Antonius Ziekenhuis
-
Utrecht, Netherlands
- UMC Utrecht
-
-
-
-
Alabama
-
Fairhope, Alabama, United States, 36532
- Thomas Hospital
-
-
Arizona
-
Scottsdale, Arizona, United States, 85258
- Scottsdale Healthcare
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72211
- Arkansas Heart Hospital
-
-
California
-
Bakersfield, California, United States, 93301
- Bakersfield Memorial Hospital
-
Fremont, California, United States, 94538
- Mission Cardiovascular Research Institute (Washington Hospital)
-
Long Beach, California, United States, 90822
- Long Beach VA Medical Center
-
Los Angeles, California, United States, 90033
- Keck Hospital of USC
-
San Francisco, California, United States, 94121
- San Francisco VA
-
-
Delaware
-
Newark, Delaware, United States, 19702
- Christiana Hospital
-
-
Florida
-
Clearwater, Florida, United States, 33756
- Morton Plant Hospital
-
Clearwater, Florida, United States, 34695
- Clearwater Cardiovascular Consultants
-
Hollywood, Florida, United States, 33021
- Memorial Regional Hospital
-
Miami, Florida, United States, 33125
- University of Miami Medical Center
-
Ocala, Florida, United States, 34471
- Mediquest (Munroe Regional Medical Center)
-
Tallahassee, Florida, United States, 32303
- Tallahassee Research Institute
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago Medical Center
-
Chicago, Illinois, United States, 60637
- Jesse Brown VAMC
-
Hinsdale, Illinois, United States, 60521
- Amita/Adventist Heart and Vascular
-
-
Indiana
-
Elkhart, Indiana, United States, 46514
- Elkhart General Healthcare
-
Indianapolis, Indiana, United States, 46290
- St Vincent Heart Center of Indiana
-
-
Iowa
-
Des Moines, Iowa, United States, 50314
- Mercy Hospital Medical Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21218
- Union Memorial Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Kalamazoo, Michigan, United States, 49008
- Borgess Heart Center
-
Petoskey, Michigan, United States, 49770
- Northern Michigan Hospital d.b.a McLaren Northern Michigan
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
-
Minnesota
-
Duluth, Minnesota, United States, 55805
- St. Mary's Duluth Clinic
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Mississippi
-
Tupelo, Mississippi, United States, 38801
- North Mississippi Health Services
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- St. Luke's Hospital
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
New Jersey
-
Browns Mills, New Jersey, United States, 08015
- Deborah Heart and Lung Center
-
Morristown, New Jersey, United States, 07960
- Morristown Medical Center
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
Mineola, New York, United States, 11501
- NYU Winthrop Hospital
-
New York, New York, United States, 10016
- NYU Langone Medical Center
-
New York, New York, United States, 10021
- Weill Cornell Medical Center
-
Rochester, New York, United States, 14621
- Rochester General Hospital
-
Syracuse, New York, United States, 13203
- St. Joseph's Hospital Health Center
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center
-
Greensboro, North Carolina, United States, 27401
- Moses Cone Memorial Hospital
-
Raleigh, North Carolina, United States, 27607
- North Carolina Heart and Vascular
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- The Christ Hospital
-
Columbus, Ohio, United States, 43214
- Riverside Methodist Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 19103
- LeHigh Valley Hospital
-
Hershey, Pennsylvania, United States, 17033
- Hershey Medical Center
-
Sayre, Pennsylvania, United States, 18840
- Robert Packer Hospital
-
-
Texas
-
Houston, Texas, United States, 77030
- The Methodist Hospital
-
Houston, Texas, United States, 77030
- Texas Heart Institute
-
Round Rock, Texas, United States, 78681
- Austin Heart
-
San Antonio, Texas, United States, 78212
- South Texas Cardiology Institute
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Medical Center
-
-
Washington
-
Seattle, Washington, United States, 98122
- Swedish Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is an eligible candidate for percutaneous coronary intervention (PCI);
- Subject has symptomatic coronary artery disease with objective evidence of ischemia or silent ischemia;
- Subject is an acceptable candidate for coronary artery bypass grafting (CABG);
- Subject has up to 3 de novo target lesions in up to 2 native coronary artery vessels, with no more than 2 lesions in a single vessel, each meeting the angiographic criteria and none of the exclusion criteria.
- Target lesion(s) must be located in a native coronary artery with a visually estimated reference vessel diameter (RVD) ≥ 2.25 mm and ≤ 4.00 mm;
Exclusion Criteria:
- The subject has cardiogenic shock, hemodynamic instability requiring inotropic or mechanical circulatory support, intractable ventricular arrhythmias, or ongoing intractable angina;
- The subject's target lesion(s) is located in the left main artery;
- The subject's target lesion(s) is located within 3 mm of the origin of the left anterior descending (LAD) coronary artery or left circumflex (LCX) coronary artery by visual estimate;
- The subject's target lesion(s) is located within a saphenous vein graft or arterial graft;
- The subject's target lesion(s) will be accessed via a saphenous vein graft or arterial graft;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
|
PCI with implantation of a DES
|
Experimental: Svelte
|
PCI with implantation of a DES
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Target Lesion Failure (TLF)
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Target Vessel Failure (TVF)
Time Frame: 6 and 12 months, and annually through 5 years
|
6 and 12 months, and annually through 5 years
|
Major Adverse Cardiac Event (MACE)
Time Frame: 6 and 12 months and annually through 5 years follow-up
|
6 and 12 months and annually through 5 years follow-up
|
Stent Thrombosis
Time Frame: 6 and 12 months and annually through 5 years follow-up
|
6 and 12 months and annually through 5 years follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Shing C Wong, MD, Svelte Medical
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kereiakes DJ, Feldman RL, Ijsselmuiden AJJ, Saito S, Amoroso G, Zidar JP, Wong SC, Stella P, Yakubov S, Lasala J, Cohen DJ, Doros G, Cutlip DE, Rao SV. Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study. Circ Cardiovasc Interv. 2021 Sep;14(9):e010609. doi: 10.1161/CIRCINTERVENTIONS.121.010609. Epub 2021 Aug 6.
- Mauri L, Doros G, Rao SV, Cohen DJ, Yakubov S, Lasala J, Wong SC, Zidar J, Kereiakes DJ. The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale. Am Heart J. 2019 Oct;216:82-90. doi: 10.1016/j.ahj.2019.07.003. Epub 2019 Jul 13.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 2, 2018
Primary Completion (Actual)
July 17, 2020
Study Completion (Actual)
March 8, 2023
Study Registration Dates
First Submitted
June 14, 2017
First Submitted That Met QC Criteria
June 14, 2017
First Posted (Actual)
June 16, 2017
Study Record Updates
Last Update Posted (Actual)
March 23, 2023
Last Update Submitted That Met QC Criteria
March 21, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IP-15-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Meditrix CorpNational University of Ireland, Galway, Ireland; Boston Scientific Japan K.K.; Fujita Health UniversityRecruitingChronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromeJapan, Ireland
-
OrbusNeichDuke Clinical Research Institute; OrbusNeich Medical K.K.CompletedCoronary Arteriosclerosis | Non ST Segment Elevation Acute Coronary SyndromeUnited States, Japan
-
Medical University of WarsawRecruitingAcute Coronary Syndrome | Chronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromePoland
-
Niguarda HospitalCompletedAcute Coronary Syndrome With ST Elevation on Electrocardiogram | Acute Coronary Syndrome Without ST Elevation on Electrocardiogram | Noncritical Coronary Artery Disease Coronary Stenosis Less Than 50 Per Cent | Aortic AneurysmsItaly
-
Sohag UniversityRecruitingLeft Main Coronary Artery Disease With Acute Coronary SyndromeEgypt
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.CompletedCoronary Arteriosclerosis | Acute Coronary SyndromesUnited States
-
University of PatrasCompletedCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)Greece
-
Deutsches Herzzentrum MuenchenDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)CompletedAcute Coronary Syndrome (ACS)Germany, Italy
-
Northwestern UniversityTerminatedACS - Acute Coronary SyndromeUnited States
Clinical Trials on DES
-
Boston Scientific CorporationLabcoat, Ltd.Completed
-
Fondazione Evidence per Attività e Ricerche Cardiovascolari...Mediolanum Cardio ResearchCompletedMyocardial Infarction
-
Henan Institute of Cardiovascular EpidemiologyRecruiting
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaRecruiting
-
Istituto Clinico Sant'AmbrogioUnknownCoronary Artery DiseaseItaly
-
Cardionovum GmbHMediolanum Cardio ResearchCompletedCoronary Artery DiseaseSpain, Italy
-
Biotronik AGBiotronik FranceActive, not recruitingMyocardial Ischemia | Coronary Artery DiseaseFrance
-
Boston Scientific CorporationLabcoat, Ltd.Completed
-
M.A. Med Alliance S.A.RecruitingCoronary Artery DiseaseFrance, Czechia, United Kingdom, Germany, Italy, Switzerland, Austria, Finland, Poland
-
Mackay Memorial HospitalUnknownAcute Myocardial Infarction | Atrial Fibrillation New Onset